Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy Subjects

NCT00675064 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

DRUG: GSK369796
DRUG: Placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]